CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS SC RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC - PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT

Authors
MANTOVANI G MACCIO A LAI P ESU S MASSA E GHIANI M ASTARA G MANCA G MASSA D LAMPIS B SUCCU G PISANO M VERSACE R PUSCEDDU G
Citation
G. Mantovani et al., CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS SC RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC - PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT, European journal of cancer, 33, 1997, pp. 58-58
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
5
Pages
58 - 58
Database
ISI
SICI code
0959-8049(1997)33:<58:CWWCAE>2.0.ZU;2-8